Identification of Genetic Factors that Modify Clinical Onset of Huntington’s Disease

Lee, Jong-Min, Wheeler, Vanessa C., Chao, Michael J., Vonsattel, Jean Paul G., Pinto, Ricardo Mouro, Lucente, Diane, Abu-Elneel, Kawther, Ramos, Eliana Marisa +19 more·2015·Cell

Cited by (659)

Items 301–400 of 659

  1. The Startling Role of Mismatch Repair in Trinucleotide Repeat Expansions
    Guy‐Franck Richard · 2021 · Cells
  2. Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington’s disease
    Jiang, Mali, Zhang, Xiaoyan, Liu, Hongshuai, LeBron, Jared, Alexandris, Athanasios, Peng, Qi, Gu, Hao, Yang, Fanghan, Li, Yuchen, Wang, Ruiling et al. · 2020 · Human Molecular Genetics
  3. Spatial and Temporal Distribution of White Matter Lesions in NOTCH2NLC-Related Neuronal Intranuclear Inclusion Disease
    Shaoping Zhong, Beini Fei, Jingzhen Liang, Yangye Lian, Jing Wang, Ying Liu, Yuwen Zhang, Jianying Liu, Xin Wang, Jing Ding · 2025 · Neurology
  4. Huntington disease-like 2: insight into neurodegeneration from an African disease
    Amanda Krause, David G. Anderson, Aline Ferreira‐Correia, Jessica Dawson, Fiona Baine, Pan P. Li, Russell L. Margolis · 2023 · Nature Reviews Neurology
  5. Ups and Downs: Mechanisms of Repeat Instability in the Fragile X-Related Disorders
    Xiao-Nan Zhao, Karen Usdin · 2016 · Genes
  6. Association Between Toll‐Like Receptor 4 (TLR4) and Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Genetic Variants and Clinical Progression of Huntington's Disease
    Romina Vuono, Antonina Kouli, Emilie M. Legault, Lauriane Chagnon, Kieren S. J. Allinson, Alberto Spada, REGISTRY Investigators of the European Huntington's Disease Network, Ida Biunno, Roger A. Barker, Janelle Drouin‐Ouellet · 2019 · Movement Disorders
  7. Focusing the pivotal role of nanotechnology in Huntington’s disease: an insight into the recent advancements
    Sukhbir Singh, Hema, Neelam Sharma, Monika Sachdeva, Tapan Behl, Ishrat Zahoor, Neeraj Kumar Fuloria, Mahendran Sekar, Shivkanya Fuloria, Vetriselvan Subramaniyan et al. · 2022 · Environmental Science and Pollution Research
  8. A Defective mRNA Cleavage and Polyadenylation Complex Facilitates Expansions of Transcribed (GAA)n Repeats Associated with Friedreich’s Ataxia
    Ryan J. McGinty, Franco J. Puleo, Anna Yu. Aksenova, Julia A. Hisey, Alexander A. Shishkin, Erika L. Pearson, Eric T. Wang, David E. Housman, Claire L. Moore, Sergei M. Mirkin · 2017 · Cell Reports
  9. Ubiquitin-Proteasome-Mediated Protein Degradation and Disorders of the Central Nervous System
    Ashok N. Hegde, Logan E. Timm, Connor J. Sivley, Shrenik Ramiyaramcharankarthic, Olivia J. Lowrimore, Brenna J. Hendrix, Teodora G. Grozdanov, William J. Anderson · 2025 · International Journal of Molecular Sciences
  10. HD and SCA1: Tales from two 30-year journeys since gene discovery
    Leslie Michels Thompson, Harry T. Orr · 2023 · Neuron
  11. Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
    Sarah Aqel, Jamil Ahmad, Iman Saleh, Aseela Fathima, Asmaa A. Al Thani, Wael M.Y. Mohamed, Abdullah A. Shaito · 2025 · Biology
  12. Magnitude of Mendelian versus complex inheritance of rare disorders
    Aravinda Chakravarti · 2021 · American Journal of Medical Genetics Part A
  13. Human Immunodeficiency Virus Infection in Huntington’s Disease is Associated with an Earlier Age of Symptom Onset
    Jordan L. Schultz, Peg Nopoulos, Pedro Gonzalez‐Alegre · 2018 · Journal of Huntington s Disease
  14. Systems-level analysis of peripheral blood gene expression in dementia patients reveals an innate immune response shared across multiple disorders
    Daniel C. Nachun, EM Ramos, A Karydas, D Dokuru, F Gao, Z Yang, V Van Berlo, R Sears, J Kramer, Adam L. Boxer et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  15. (Dys)function Follows Form: Nucleic Acid Structure, Repeat Expansion, and Disease Pathology in FMR1 Disorders
    Xiao-Nan Zhao, Karen Usdin · 2021 · International Journal of Molecular Sciences
  16. Seeing Clearly in the Twilight: The Clinical and Forensic Relevance of the Indeterminate/Borderline Range in Multivariate Models of Performance Validity Assessment
    László A. Erdődi · 2024 · Psychological Injury and Law
  17. Discrepancy in prevalence of Huntington's disease in two Swedish regions
    Anna-Karin Roos, Lars Wiklund, Katarina Laurell · 2017 · Acta Neurologica Scandinavica
  18. A Genetic Study of Psychosis in Huntington’s Disease: Evidence for the Involvement of Glutamate Signaling Pathways
    Debby W. Tsuang, Tiffany A. Greenwood, Suman Jayadev, Marie Y. Davis, Andrew Shutes‐David, Thomas D. Bird · 2018 · Journal of Huntington s Disease
  19. Chromatin accessibility and transcription dynamics during in vitro astrocyte differentiation of Huntington’s Disease Monkey pluripotent stem cells
    Alexandra Goodnight, Isaac Kremsky, Sujittra Khampang, Yoon Hee Jung, James M. Billingsley, Steven E. Bosinger, Victor G. Corces, Anthony W.S. Chan · 2019 · Epigenetics & Chromatin
  20. DNA repair in trinucleotide repeat ataxias
    Wai Yan Yau, Emer O’Connor, Roisin Sullivan, Layan Akijian, Nicholas William Wood · 2018 · FEBS Journal
  21. Metamorphic Testing for Quality Assurance of Protein Function Prediction Tools
    Morteza Pourreza Shahri, Madhusudan Srinivasan, Gillian L. Reynolds, Diane Bimczok, Indika Kahanda, Upulee Kanewala · 2019 · IEEE International Conference on Artificial Intelligence Testing (AITest)
  22. Towards genomic database of Alexander disease to identify variations modifying disease phenotype
    Rei Yasuda, Masakazu Nakano, Tomokatsu Yoshida, Ryuichi Sato, Hiroko Adachi, Yuichi Tokuda, Ikuko Mizuta, Kozo Saito, Jun Matsuura, Masanori Nakagawa et al. · 2019 · Scientific Reports
  23. Age of onset in Huntington’s disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes
    Geerte Stuitje, Martine J. van Belzen, Sarah L. Gardiner, Willeke van Roon‐Mom, Merel W. Boogaard, Sarah J. Tabrizi, Raymund A.C. Roos, N. Ahmad Aziz · 2017 · Brain
  24. Genetic and Epigenetic Interplay Define Disease Onset and Severity in Repeat Diseases
    Lise Barbé, Steven M. Finkbeiner · 2022 · Frontiers in Aging Neuroscience
  25. HTT-OMNI: A Web-based Platform for Huntingtin Interaction Exploration and Multi-omics Data Integration
    Michelle A. Kennedy, Todd M. Greco, Bokai Song, Ileana M. Cristea · 2022 · Molecular & Cellular Proteomics
  26. Divergent cognitive trajectories in early stage Huntington's disease: A 3‐year longitudinal study
    Saül Martínez‐Horta, Jesús Pérez‐Pérez, Javier Oltra‐Cucarella, Frederic Sampedro, Andrea Horta‐Barba, Arnau Puig‐Davi, Javier Pagonabarraga, Jaime Kulisevsky · 2023 · European Journal of Neurology
  27. Huntington's Disease with Small CAG Repeat Expansions
    Anna Heinzmann, Sabrina Sayah, François‐Xavier Lejeune, Valérie Hahn‐Barma, Marc Teichmann, Marie‐Lorraine Monin, Enrica Marchionni, Fleur Gérard, Perrine Charles, Jérémie Pariente et al. · 2023 · Movement Disorders
  28. Suppression of Huntington’s Disease Somatic Instability by Transcriptional Repression and Direct CAG Repeat Binding
    Ella W. Mathews, Sydney R. Coffey, Annette Gärtner, Jillian Belgrad, Robert M. Bragg, Daniel O’Reilly, Jeffrey P. Cantle, Cassandra A. McHugh, Ashley Summers, Joachim Fentz et al. · 2025 · Nature Communications
  29. The Therapeutic Potential of Neuronal K-Cl Co-Transporter KCC2 in Huntington’s Disease and Its Comorbidities
    Katie Andrews, Sunday Solomon Josiah, Jinwei Zhang · 2020 · International Journal of Molecular Sciences
  30. Targeting Expanded Repeats by Small Molecules in Repeat Expansion Disorders
    Masayuki Nakamori, Hideki Mochizuki · 2020 · Movement Disorders
  31. A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis
    Yan Hua Lee, Yu‐Shuen Tsai, Che‐Chang Chang, Chun-Chen Ho, Hsiu‐Ming Shih, Hui‐Mei Chen, Hsing‐Lin Lai, Chia‐Wei Lee, Yi‐Chung Lee, Yi‐Chu Liao et al. · 2021 · Movement Disorders
  32. The microbiota-gut-brain axis in Huntington's disease
    Chloe J. Love, Bethany A. Masson, Carolina Gubert, Anthony John Hannan · 2022 · International review of neurobiology
  33. Identification of symbol digit modality test score extremes in Huntington's disease
    Ulrike Braisch, Rainer Muche, Dietrich Rothenbacher, G. Bernhard Landwehrmeyer, Jeffrey D. Long, Michael Orth, REGISTRY Investigators of the European Huntington's Disease Network and COHORT Investigators of the Huntington Study Group · 2019 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  34. ( CAG )n loci as genetic modifiers of age at onset in patients with spinocerebellar ataxia type 1 from mainland China
    Panhong Wang, Z. Chen, Yun Peng, Li Hua Cao, X. Li, C. Wang, H. Yang, H. Peng, Yuting Shi, X. Zhou et al. · 2019 · European Journal of Neurology
  35. Findings and insights from the genetic investigation of age of first reported occurrence for complex disorders in the UK Biobank and FinnGen
    Yen‐Chen Anne Feng, Tian Ge, Mattia Cordioli, FinnGen, Andrea Ganna, Jordan W. Smoller, Benjamin M. Neale · 2020 · medRxiv
  36. Update on the Symptomatic Treatment of Huntington’s Disease: From Pathophysiology to Clinical Practice
    Gonzalo Olmedo‐Saura, Eugenio Bernardi, Lidia Bojtos, Saül Martínez‐Horta, Javier Pagonabarraga, Jaime Kulisevsky, Jesús Pérez‐Pérez · 2025 · International Journal of Molecular Sciences
  37. Loss of TDP-43 promotes somatic CAG repeat expansion in Huntington’s disease knock-in mice
    Dazhang Bai, Longhong Zhu, Qingqing Jia, Xuezhi Duan, Laiqiang Chen, Xiang Wang, Junqi Hou, Guohui Jiang, Su Yang, Shihua Li et al. · 2023 · Progress in Neurobiology
  38. Modification of Huntington’s disease by short tandem repeats
    Eun Pyo Hong, Eliana Marisa Ramos, N. Ahmad Aziz, Thomas H. Massey, Branduff McAllister, Sergey V. Lobanov, Lesley Jones, Peter Holmans, Seung Kwak, Michael Orth et al. · 2024 · Brain Communications
  39. Huntingtin is an RNA binding protein and participates in NEAT1 -mediated paraspeckles
    Manisha Yadav, Rachel Harding, Tiantian Li, Xin Xu, Terence Gall-Duncan, Mahreen Khan, Costanza Ferrari Bardile, Glen Lester Sequiera, Shili Duan, Renu Chandrasekaran et al. · 2024 · Science Advances
  40. Structural and Dynamical Properties of Nucleic Acid Hairpins Implicated in Trinucleotide Repeat Expansion Diseases
    Feng Pan, Pengning Xu, Christopher Roland, Celeste Sagui, Keith Weninger · 2024 · Biomolecules
  41. Mitochondrial Biology and the Identification of Biomarkers of Huntington’s Disease
    Andreas Neueder, Michael Orth · 2020 · Neurodegenerative Disease Management
  42. The Association between CAG Repeat Length and Age of Onset of Juvenile-Onset Huntington’s Disease
    Jordan L. Schultz, Amelia D. Moser, Peg Nopoulos · 2020 · Brain Sciences
  43. The Effect of Education on Symptom Onset and Severity of Huntington's Disease
    Kristina K. Cain, Joseph L. Flanigan, William Alexander Dalrymple, James Patrie, Madaline B. Harrison, Matthew J. Barrett · 2021 · Movement Disorders Clinical Practice
  44. Special Issue: DNA Repair and Somatic Repeat Expansion in Huntington’s Disease
    Lesley Jones, Vanessa Chantal Wheeler, Christopher E. Pearson · 2021 · Journal of Huntington s Disease
  45. Msh3 and Pms1 Set Neuronal CAG-repeat Migration Rate to Drive Selective Striatal and Cortical Pathogenesis in HD Mice
    Nan Wang, Shasha Zhang, Peter Langfelder, Lalini Ramanathan, Mary Plascencia, Fuying Gao, Raymond Vaca, Xiaofeng Gu, Linna Deng, Leonardo E. Dionisio et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  46. Schizophrenia polygenic risk scores in youth mental health: preliminary associations with diagnosis, clinical stage and functioning
    Jacob J. Crouse, Joanne Sarah Carpenter, Frank Iorfino, Tian Lin, Nicholas Ho, Enda M. Byrne, Anjali K. Henders, Leanne M. Wallace, Daniel Francis Hermens, Elizabeth M. Scott et al. · 2021 · BJPsych Open
  47. Remote assessment of myotonic dystrophy type 1: A feasibility study
    Johanna Hamel, Peter D. Creigh, Jeanne M. Dekdebrun, Katy J. Eichinger, Charles A. Thornton · 2022 · Muscle & Nerve
  48. Dementia and neurodegenerative disorder: An introduction
    Swapnali Vasant Birajdar, Manisha Mulchandani, Farhan Mazahir, Awesh Kumar Yadav · 2022 · Elsevier eBooks
  49. Dosage sensitivity to Pumilio1 variants in the mouse brain reflects distinct molecular mechanisms
    Salvatore Botta, Nicola de Prisco, Alexei Chemiakine, Vicky L. Brandt, Maximilian Cabaj, Purvi R. Patel, Ella Doron‐Mandel, Colton J. Treadway, Marko Jovanović, Nicholas Gene Brown et al. · 2023 · The EMBO Journal
  50. A cyclic pyrrole-imidazole polyamide reduces pathogenic RNA in CAG/CTG triplet repeat neurological disease models
    Susumu Ikenoshita, Kazuya Matsuo, Yasushi Yabuki, Kosuke Kawakubo, Sefan Asamitsu, Karin Hori, Shingo Usuki, Yuki Hirose, Toshikazu Bando, Kimi Araki et al. · 2023 · Journal of Clinical Investigation
  51. Posttranscriptional regulation of FAN1 by miR-124-3p at rs3512 underlies onset-delaying genetic modification in Huntington’s disease
    Kyung‐Hee Kim, Eun Pyo Hong, Yukyeong Lee, Zachariah L. McLean, Emanuela Elezi, Ramee Lee, Seung Kwak, Branduff McAllister, Thomas H. Massey, Sergey V. Lobanov et al. · 2024 · Proceedings of the National Academy of Sciences
  52. Recurrent DNA nicks drive massive expansions of (GAA) n repeats
    Liangzi Li, W. Shem Scott, Alexandra N. Khristich, Jillian F. Armenia, Sergei M. Mirkin · 2024 · Proceedings of the National Academy of Sciences
  53. Mechanisms underlying neurodegeneration in Huntington disease: applications to novel disease-modifying therapies
    Christopher A. Ross, Martin Kronenbuerger, Wenzhen Duan, Russell L. Margolis · 2017 · Handbook of clinical neurology
  54. Murine Models of Huntington’s Disease for Evaluating Therapeutics
    Natalia Kosior, Blair R. Leavitt · 2018 · Methods in molecular biology
  55. Clinical and genetic characteristics of late‐onset Huntington's disease in a large European cohort
    Martina Petracca, Sonia Di Tella, Marcella Solito, Paola Zinzi, Maria Rita Lo Monaco, Giulia Di Lazzaro, Paolo Calabresi, Maria Caterina Silveri, Anna Rita Bentivoglio · 2022 · European Journal of Neurology
  56. Is There an Association of Physical Activity with Brain Volume, Behavior, and Day-to-day Functioning? A Cross Sectional Design in Prodromal and Early Huntington Disease
    McKenzie Wallace, Nancy R. Downing, Spencer G. Lourens, James A. Mills, Ji‐In Kim, Jeffrey D. Long, Jane S. Paulsen, PREDICT-HD Investigators and Coordinators of the Huntington Study Group · 2016 · PLoS Currents
  57. The Complexity of Clinical Huntington’s Disease: Developments in Molecular Genetics, Neuropathology and Neuroimaging Biomarkers
    Lynette J. Tippett, Henry John Waldvogel, Russell G. Snell, Jean‐Paul Vonsattel, Anne B. Young, Richard L. M. Faull · 2017 · Advances in neurobiology
  58. DNA mismatch repair in trinucleotide repeat instability
    Jinzhen Guo, Luping Chen, Guo‐Min Li · 2017 · Science China Life Sciences
  59. Predictive testing for Huntington disease over 24 years: Evolution of the profile of the participants and analysis of symptoms
    Francis Ramond, Isabelle Quadrio, Laurence Le Vavasseur, Hélène Chaumet, Fabrice Boyer, Muriel Bost, Elisabeth Ollagnon‐Roman · 2019 · Molecular Genetics & Genomic Medicine
  60. Interaction between somatic mutations and germline variants contributes to clinical heterogeneity in cancer
    Julian Musa, Thomas G. P. Grünewald · 2019 · Molecular & Cellular Oncology
  61. What do we know about the variability in survival of patients with amyotrophic lateral sclerosis?
    Pamela McCombe, Fleur C. Garton, Matthew Katz, Naomi R. Wray, Robert D. Henderson · 2020 · Expert Review of Neurotherapeutics
  62. Transplantation of human embryonic stem cells alleviates motor dysfunction in AAV2-Htt171-82Q transfected rat model of Huntington’s disease
    Jaisan Islam, Kyoung Ha So, Elina KC, Hyeong Cheol Moon, Aryun Kim, Sang Hwan Hyun, Soochong Kim, Young Seok Park · 2021 · Stem Cell Research & Therapy
  63. A Double-Pronged Sword: XJB-5-131 Is a Suppressor of Somatic Instability and Toxicity in Huntington’s Disease
    Pater Wipf, Aris A. Polyzos, Cynthia T. McMurray · 2021 · Journal of Huntington s Disease
  64. Global proteome metastability response in isogenic animals to missense mutations and polyglutamine expansions in aging
    Xiaojing Sui, Miguel A. Prado, João A. Paulo, Steven P. Gygi, Daniel J. Finley, Richard I. Morimoto · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  65. The frequency and clinical impact of synonymous HTT loss-of-interruption and duplication-of-interruption variants in a diverse HD cohort
    Jessica Dawson, Chris Kay, Hailey Findlay Black, Stephanie Bortnick, Kyla Javier, Qingwen Xia, Akshdeep Sandhu, Christina Maree Buchanan, Virginia M. Hogg, Florence Chang et al. · 2024 · Genetics in Medicine
  66. Telomere length as a modifier of age-at-onset in Huntington disease: a two-sample Mendelian randomization study
    N. Ahmad Aziz, Patrick Weydt · 2018 · Journal of Neurology
  67. Advances in the discovery of genetic risk factors for complex forms of neurodegenerative disorders: contemporary approaches, success, challenges and prospects
    Sumeet Kumar, Navneesh Yadav, Sanjay Pandey, Bittianda Kuttapa Thelma · 2018 · Journal of Genetics
  68. Inconsistencies in histone acetylation patterns among different HD model systems and HD post-mortem brains
    Pritika J. Narayan, Suzanne J. Reid, Emma L. Scotter, Ailsa L. McGregor, Nasim F. Mehrabi, Malvindar K. Singh‐Bains, Michelle Glass, Richard L. M. Faull, Russell G. Snell, Mike Dragunow · 2020 · Neurobiology of Disease
  69. Haplotype-specific insertion-deletion variations for allele-specific targeting in Huntington's disease
    Jun Wan Shin, Aram Shin, Seri S. Park, Jong‐Min Lee · 2022 · Molecular Therapy — Methods & Clinical Development
  70. Somatic and intergenerational G4C2 hexanucleotide repeat instability in a human C9orf72 knock-in mouse model
    Nada Kojak, Junko Kuno, Kristina E Fittipaldi, Ambereen Khan, David Wenger, Michael Glasser, Roberto Antonio Donnianni, Yajun Tang, Jade Zhang, Katie Huling et al. · 2024 · Nucleic Acids Research
  71. Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington’s disease
    Simone Maestri, Davide Scalzo, Gianluca Damaggio, Martina Zobel, Dario Besusso, Elena F. Cattaneo · 2024 · Nucleic Acids Research
  72. Translatable plasma and CSF biomarkers for use in mouse models of Huntington’s disease
    Marie K. Bondulich, Jemima M Phillips, María Cañibano-Pico, Iulia M Nita, Lauren M. Byrne, Edward J. Wild, Gillian P. Bates · 2023 · Brain Communications
  73. Polyglutamine disease proteins: Commonalities and differences in interaction profiles and pathological effects
    Megan Bonsor, Orchid Ammar, Sigrid Schnoegl, Erich E. Wanker, Eduardo Silva Ramos · 2024 · PROTEOMICS
  74. One decade ago, one decade ahead in huntington's disease
    Edward J. Wild, Sarah J. Tabrizi · 2019 · Movement Disorders
  75. Defective repair of topoisomerase I induced chromosomal damage in Huntington’s disease
    Nelma M. Palminha, Cleide Dos Santos Souza, Jon Griffin, Chunyan Liao, Laura Ferraiuolo, Sherif F. El‐Khamisy · 2022 · Cellular and Molecular Life Sciences
  76. Unraveling progression subtypes in people with Huntington’s disease
    Tamara Raschka, Zexin Li, Heiko Gaßner, Zacharias Kohl, Jelena Jukic, Franz Marxreiter, Holger Fröhlich · 2024 · The EPMA Journal
  77. APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats
    Rebecca E. Brown, Margo Coxon, Benjamin B. Larsen, Maxwell J. Allison, Ariana Chadha, Isabelle Mittelstadt, Tony M. Mertz, Steven A. Roberts, C. Freudenreich · 2025 · Proceedings of the National Academy of Sciences of the United States of America
  78. Therapeutic targeting of mismatch repair proteins in triplet repeat expansion diseases
    Paulina Marzec, Madeleine Richer, Robert S. Lahue · 2025 · DNA repair
  79. Juvenile‐Onset Huntington's Disease in Peru: A Case Series of 32 Patients
    Anastasia Vishnevetsky, Mario Cornejo‐Olivas, Elison H. Sarapura‐Castro, Miguel Inca‐Martinez, Danielle Galler Rabinowitz, Karina Milla‐Neyra, Pilar Mazzetti, Thomas D. Bird · 2022 · Movement Disorders Clinical Practice
  80. The Impact of Family History on the Clinical Features of Huntington’s Disease
    Gabe Kringlen, Lisa M. Kinsley, Sharon A. Aufox, Gerald W. Rouleau, Danny Bega · 2017 · Journal of Huntington s Disease
  81. Natural Genetic Variation in Yeast Reveals That NEDD4 Is a Conserved Modifier of Mutant Polyglutamine Aggregation
    Theodore W. Peters, Christopher S. Nelson, Akos A. Gerencser, Kathleen J. Dumas, Brandon Tavshanjian, Kyu Chul Chang, Gordon J. Lithgow, Robert E. Hughes · 2018 · G3 Genes Genomes Genetics
  82. Wide range of reduced penetrance alleles in spinal and bulbar muscular atrophy: a model-based approach
    Achilleas Laskaratos, Marianthi Breza, Georgia Karadima, Georgios Koutsis · 2020 · Journal of Medical Genetics
  83. Brain Cell Type-Specific Nuclear Proteomics Is Imperative to Resolve Neurodegenerative Disease Mechanisms
    Ruth S. Nelson, Eric B. Dammer, Juliet V. Santiago, Nicholas T. Seyfried, Srikant Rangaraju · 2022 · Frontiers in Neuroscience
  84. Base editing strategies to convert CAG to CAA diminish the disease-causing mutation in Huntington’s disease
    Doo Eun Choi, Jun Wan Shin, Sophia Zeng, Eun Pyo Hong, Jae-Hyun Jang, Jacob M. Loupe, Vanessa C. Wheeler, Hannah E. Stutzman, Ben Kleinstiver, Jong‐Min Lee · 2023 · eLife
  85. Ubiquitin-related network underlain by (CAG)n loci modulate age at onset in Machado-Joseph disease
    Zhao Chen, Chunrong Wang, Caifa Zheng, Zhe Long, Li Hua Cao, Xunhua Li, Huifang Shang, Xinzhen Yin, Baorong Zhang, Jingyu Liu et al. · 2017 · Brain
  86. Huntington’s disease onset is determined by length of uninterrupted CAG, not encoded polyglutamine, and is modified by DNA maintenance mechanisms
    Jong‐Min Lee, Kevin Correia, Jacob M. Loupe, Kyung‐Hee Kim, Douglas Barker, Eun Pyo Hong, Michael J. Chao, Jeffrey D. Long, Diane E. Lucente, Jean‐Paul Vonsattel et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
  87. Machine learning in Huntington’s disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Jasper Ouwerkerk, Stephanie Feleus, Kasper F. van der Zwaan, Yunlei Li, Marco Roos, Willeke van Roon‐Mom, Susanne Tamara de Bot, Katherine Wolstencroft, Eleni Mina · 2023 · Orphanet Journal of Rare Diseases
  88. Fructose-2,6-bisphosphate restores DNA repair activity of PNKP and ameliorates neurodegenerative symptoms in Huntington’s disease
    Anirban Chakraborty, Sravan Gopalkrishnashetty Sreenivasmurthy, Wyatt Miller, Weihan Huai, Tapan Biswas, Santi M. Mandal, Lisardo Boscá, Balaji Krishnan, Gourisankar Ghosh, Tapas K. Hazra · 2024 · Proceedings of the National Academy of Sciences
  89. Adult phenotypes of genetic developmental and epileptic encephalopathies
    Angeliki Vakrinou, Susanna Pagni, James Dominic Mills, Lisa M. S. Clayton, Simona Balestrini, Sanjay M. Sisodiya · 2024 · Brain Communications
  90. Neuroimaging Techniques in Huntington's Disease: A Critical Review
    Mena Farag, Harry D. J. Knights, Rachael I. Scahill, Peter McColgan, Carlos Estevez‐Fraga · 2025 · Movement Disorders Clinical Practice
  91. Pathogenesis of polyglutamine diseases: Piecing together a complex molecular puzzle
    Esmeralda Villavicencio Gonzalez, Huda Yahya Zoghbi · 2025 · The Journal of Experimental Medicine
  92. Mechanism of trinucleotide repeat expansion by MutSβ-MutLγ and contraction by FAN1
    Issam Senoussi, Valentina Mengoli, Arianna Cerana, Andrea Rinaldi, Andrés Marco, Giordano Reginato, Simone G. Moro, Ananya Acharya, Megha Roy, Akshay Jayachandran et al. · 2025 · Nature Communications
  93. Selective targeting of mutant huntingtin intron 1 improves rescue provided by antisense oligonucleotides in Huntington’s disease mice
    Robert M. Bragg, Christian Landles, Edward J. Smith, Georgina F Osborne, Ella W. Mathews, Jeffrey P. Cantle, Gillian P. Bates, Jeffrey B. Carroll · 2026 · Science Translational Medicine
  94. Identification of extreme motor phenotypes in Huntington's disease
    Ulrike Braisch, Birgit Hay, Rainer Muche, Dietrich Rothenbacher, G. Bernhard Landwehrmeyer, Jeffrey D. Long, Michael Orth, REGISTRY Investigators of the European Huntington's Disease Network and COHORT Investigators of the Huntington Study Group · 2016 · American Journal of Medical Genetics Part B Neuropsychiatric Genetics
  95. Huntington’s Chorea—a Rare Neurodegenerative Autosomal Dominant Disease: Insight into Molecular Genetics, Prognosis and Diagnosis
    Pratik Talukder, Annapurna Jana, Shrirupa Dhar, Saikat Ghosh · 2021 · Applied Biochemistry and Biotechnology
  96. CAG repeat expansions create splicing acceptor sites and produce aberrant repeat-containing RNAs
    Rachel Anderson, Michael R. Das, Yeonji Chang, Kelsey L. Farenhem, Cameron O. Schmitz, Ankur Jain · 2024 · Molecular Cell
  97. Methods for Assessing DNA Repair and Repeat Expansion in Huntington’s Disease
    Thomas H. Massey, Branduff McAllister, Lesley Jones · 2018 · Methods in molecular biology
  98. Psychiatric morbidity and poor follow-up underlie suboptimal functional and survival outcomes in Huntington’s disease
    Nikhil Ratna, Nitish L. Kamble, Sowmya Devatha Venkatesh, Meera Purushottam, Pramod Kumar Pal, Sanjeev Jain · 2020 · BMC Neurology
  99. Association Analysis of Chromosome X to Identify Genetic Modifiers of Huntington’s Disease
    Eun Pyo Hong, Michael J. Chao, Thomas H. Massey, Branduff McAllister, Sergey V. Lobanov, Lesley Jones, Peter Holmans, Seung Kwak, Michael Orth, Marc Ciosi et al. · 2021 · Journal of Huntington s Disease
  100. Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14‐year follow‐up study
    Salvatore Mazzeo, Filippo Emiliani, Silvia Bagnoli, Sonia Padiglioni, Vittoria Conti, Assunta Ingannato, Giulia Giacomucci, Juri Balestrini, Camilla Ferrari, Sandro Sorbi et al. · 2022 · European Journal of Neurology